Human Herpesvirus 6B in the Transplant Recipient: When to Worry, When to Act
- 26 December 2018
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 7 (suppl_2) , S75-S78
Abstract
Human herpesvirus 6B (HHV-6B) is a ubiquitous pathogen that infects most individuals before the age of three years. HHV-6B reactivates in approximately 40% of transplant recipients where it has been associated with a number of important outcomes, especially in allogeneic transplant recipients. This article will review the epidemiology, clinical manifestations, diagnosis, and treatment of HHV-6B infection.Keywords
This publication has 29 references indexed in Scilit:
- Laboratory and Clinical Aspects of Human Herpesvirus 6 InfectionsClinical Microbiology Reviews, 2015
- Chromosomally integrated HHV-6: impact on virus, cell and organismal biologyCurrent Opinion in Virology, 2014
- Classification of HHV-6A and HHV-6B as distinct virusesArchives of Virology, 2013
- Chromosomally integrated human herpesvirus 6: questions and answersReviews in Medical Virology, 2011
- Human herpesvirus-6 entry into the central nervous system through the olfactory pathwayProceedings of the National Academy of Sciences, 2011
- Chromosomal Integration of Human Herpesvirus 6 Is the Major Mode of Congenital Human Herpesvirus 6 InfectionPediatrics, 2008
- Transmission of Integrated Human Herpesvirus 6 through Stem Cell Transplantation: Implications for Laboratory DiagnosisThe Journal of Infectious Diseases, 2006
- Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brainJournal of Medical Virology, 2001
- Human herpesvirus 6 infection in neoplastic and normal brain tissueJournal of Medical Virology, 2000
- Neuroinvasion And Persistence Of Human Herpesvirus 6 In ChildrenThe Journal of Infectious Diseases, 1994